
    
      The main body of this study has six intervention arms, five VS-505 treatment arms of various
      dosage plus one active control arm of Sevelamer Carbonate, each consists 25 subjects. Prior
      to this main part, a dose escalating cohort of 25 subjects is added to evaluate the
      tolerability of VS-505 in Chinese patient population.
    
  